Cargando…
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Psoriasis is a frequent chronic inflammatory skin disease, nowadays considered a major global health problem. Several new drugs, targeting the IL-23/IL-17A pathway, have been recently licensed or are in clinical development. These therapies represent a major improvement of the way in which psoriasis...
Autores principales: | Brembilla, Nicolo Costantino, Senra, Luisa, Boehncke, Wolf-Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088173/ https://www.ncbi.nlm.nih.gov/pubmed/30127781 http://dx.doi.org/10.3389/fimmu.2018.01682 |
Ejemplares similares
-
Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2023) -
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020) -
Autoreactive T-Lymphocytes in Inflammatory Skin Diseases
por: Boehncke, Wolf-Henning, et al.
Publicado: (2019) -
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
por: Brevi, Arianna, et al.
Publicado: (2020) -
The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)